Literature DB >> 15841193

Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole.

Ashish Sharma1, Sriram Ramaswamy, Vijay K Dewan.   

Abstract

Entities:  

Year:  2005        PMID： 15841193      PMCID： PMC1076450          DOI： 10.4088/pcc.v07n0107

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  6 in total

1.  Aripiprazole-induced improvement in tardive dyskinesia.

Authors:  Harpreet S Duggal
Journal:  Can J Psychiatry       Date:  2003-12       Impact factor: 4.356

2.  Ziprasidone-related tardive dyskinesia.

Authors:  Martin E Keck; Marianne B Müller; Elisabeth B Binder; Annette Sonntag; Florian Holsboer
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

3.  An experimental model of tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

4.  Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.

Authors:  A Inoue; S Miki; M Seto; T Kikuchi; S Morita; H Ueda; Y Misu; Y Nakata
Journal:  Eur J Pharmacol       Date:  1997-02-19       Impact factor: 4.432

Review 5.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

Authors:  J M Kane; J M Smith
Journal:  Arch Gen Psychiatry       Date:  1982-04

6.  Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Authors:  Kevin D Burris; Thaddeus F Molski; Cen Xu; Elaine Ryan; Katsura Tottori; Tetsuro Kikuchi; Frank D Yocca; Perry B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030
  6 in total
  5 in total

1.  A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole.

Authors:  Hannah E Brown; Alice W Flaherty; Donald C Goff; Oliver Freudenreich
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Marked improvement in chronic tardive dyskinesia after changing to aripiprazole.

Authors:  Richard C Christensen; Lorrie K Garces
Journal:  Psychiatry (Edgmont)       Date:  2006-03

3.  Tardive dyskinesia: treatment with aripiprazole.

Authors:  Na-Ri Kang; Moon-Doo Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

4.  Treatment of tardive dyskinesia with aripiprazole.

Authors:  Ricardo S Osorio; L Agüera-Ortiz; A Hurtado de Mendoza; I Ramos; T Palomo
Journal:  Neurotox Res       Date:  2009-10-14       Impact factor: 3.911

5.  Role of aripiprazole in treatment-resistant schizophrenia.

Authors:  Nilufar Mossaheb; Rainer M Kaufmann
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-29       Impact factor: 2.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.